Dr. Bryan Douglas Goldberg, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 41 Brewster Rd, Bristol, CT 06010 Phone: 860-585-3433 Fax: 860-585-3910 |
Dr. Jeffrey Charles Lafrance, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 41 Brewster Rd, Bristol, CT 06010 Phone: 860-585-3433 |
Ronald L Falit, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 539 Farmington Ave, Bristol, CT 06010 Phone: 860-314-6046 Fax: 860-314-6047 |
Dr. Payton Duke Turpin, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25 Collins Rd, Bristol, CT 06010 Phone: 860-584-4537 Fax: 860-584-4538 |
Dr. Ian Schreiner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 Brewster Rd, Bristol, CT 06010 Phone: 860-585-3000 |
Daniel Schwartz, MD Emergency Medicine - Undersea and Hyperbaric Medicine Medicare: Medicare Enrolled Practice Location: 41 Brewster Rd, Bristol, CT 06010 Phone: 860-585-3397 Fax: 860-585-3971 |
Dr. John M Montminy, D.O Emergency Medicine - Undersea and Hyperbaric Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Pine St, The Hospital Of Central Connecticut-brisol Family Cente, Bristol, CT 06010 Phone: 860-545-3112 Fax: 904-446-3013 |
Dr. Jennifer Muneyyirci Dugan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Bristol Hospital, Brewster Road, Bristol, CT 06011 Phone: 860-585-3273 |
James P. Walden, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1215 Farmington Ave, Bristol, CT 06010 Phone: 860-516-5931 |
News Archive
Women who underwent breast reduction surgery before age 25 continue to report lasting benefits 10 to 30 years following the procedure, according to a study in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
QLT Inc. announced that its wholly-owned subsidiary, QLT USA, Inc. (formerly Atrix Laboratories, Inc.) has reached an agreement to settle the litigation captioned "TAP Pharmaceutical Products Inc., Takeda Chemical Industries, Ltd. and Wako Pure Chemical Industries, Ltd. v. Atrix Laboratories, Inc. and Sanofi-Synthelabo Inc.," # 03-C-7822, United States District Court for the Northern District of Illinois and the appeal pending therefrom in the United States Court of Appeals for the Federal Circuit.
New research from La Trobe University has revealed that 30 per cent of Australians recently reduced the quantity of their alcohol consumption and a further 29 per cent reduced the frequency of their drinking, while six per cent kicked the habit for good.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.
Higher consumption of dietary trans fatty acids (dTFA), commonly used in processed foods to improve taste, texture and durability, has been linked to worsened memory function in men 45 years old and younger, according to a University of California, San Diego School of Medicine study published online on June 17 in PLOS ONE.
› Verified 2 days ago